Clinical validation of the tempus xT next-generation targeted oncology sequencing assay
Sign Up to like & getrecommendations! Published in 2019 at "Oncotarget"
DOI: 10.18632/oncotarget.26797
Abstract: We developed and clinically validated a hybrid capture next generation sequencing assay to detect somatic alterations and microsatellite instability in solid tumors and hematologic malignancies. This targeted oncology assay utilizes tumor-normal matched samples for highly… read more here.
Keywords: sequencing assay; clinical validation; targeted oncology; next generation ... See more keywords